TRPV3 and lung carcinoma: TRPV3 oncogenic activity was demonstrated in lung cancer, where TRPV3 expression was associated with short overall survival and Ca2+-mediated increased proliferation via Ca2+/calmodulin-dependent kinase II (CaMKII) [164].